SCHEMBL22796299

SCHEMBL22796299

CCC(C)(C)c1onc(C)c1C#N

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.33
LMNA P02545 1/20 0.33
EPHX2 P34913 1/20 0.33
CYP1A2 P05177 1/20 0.33
HIF1A Q16665 1/20 0.33
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20320364 0.86 EPHX2 (0.32) ALDH1A1LMNAEPHX2CYP1A2HIF1A
SCHEMBL22796300 0.86 ALDH1A1 (0.36) ALDH1A1LMNAEPHX2CYP1A2HIF1A
SCHEMBL12245183 0.81 ALDH1A1 (0.36) ALDH1A1LMNAEPHX2CYP1A2HIF1A
SCHEMBL22795795 0.80 ALDH1A1 (0.33) ALDH1A1LMNAEPHX2CYP1A2HIF1A
SCHEMBL12826159 0.75
SCHEMBL22795796 0.74 ALDH1A1 (0.33) ALDH1A1LMNAEPHX2HTT
SCHEMBL12298669 0.69 ALDH1A1 (0.36) ALDH1A1LMNAEPHX2CYP1A2HIF1A
SCHEMBL22795792 0.68
SCHEMBL20320357 0.66
SCHEMBL5153576 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200390100-A1 SUBSTITUTED N-HETEROCYCLYL- AND N-HETEROARYL-TETRAHYDROPYRIMIDINONES AND THE SALTS THEREOF, AND THE USE OF SAME AS HERBICIDAL ACTIVE SUBSTANCES BAYER AG (DE) 2020-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200390100-A1 SUBSTITUTED N-HETEROCYCLYL- AND N-HETEROARYL-TETRAHYDROPYRIMIDINONES AND THE SALTS THEREOF, AND THE USE OF SAME AS HERBICIDAL ACTIVE SUBSTANCES DDT, NOTUM, AGPS ALDH1A1 201/4885LMNA 3862/4885EPHX2 474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.